Skip to content
Sign in
Venture capitalBacked 1 network startup

Northern Gritstone

Manchester/Leeds/Sheffield university-founded investor (£312M) backing spin-outs and IP-rich businesses in the North of England.

Manchester, United Kingdom
Ticket
—Not published
Assets under management
—
Founded
2021
Stages
Seedto Series A
Network startups backed
1
Co-investors
2most often with Deepbridge Capital

How they invest

Deep tech, life sciences, health and AI spin-outs and IP-rich companies in Northern England.

Stage and ticket

Seed and Series A.

Geography

United Kingdom (North of England).

What makes them say yes

  • University IP from Manchester, Leeds, Sheffield or the North
  • Deep tech/life science
  • Seed/A

Red flags

  • No Northern England base

Sectors

  • Deep tech & materials
  • Biotech & life sciences
  • HealthTech
  • AI & software

Stages

  • Seed
  • Series A

Geographies

  • United Kingdom

How to approach

Ask Ocuwell (Northern Gritstone seed) for an introduction.

Partners

  • Duncan JohnsonCEO
  • Marion BernardChief Investment Officer
  • Lord Jim O'NeillChair

Portfolio

1 network startup · no other company

Ocuwell (ophthalmic diagnostics) alongside LYVA Labs and Deepbridge.

Gaps in the portfolio

  • AI
  • Deep tech materials

Network startups

  • Ocuwell LimitedSWC 2026 Finalist

    United Kingdom · MedTech & devices

    University of Liverpool spin-off making corneal topography portable with OCUTOP, a handheld device matching reference machines.

Network startups that fit

3 analysed

UK/Bulgarian start-up turning top experts into on-premise “AI twins” for training and know-how retention in nuclear, pharma and defense.

UK AI knowledge management — UK; Northern base unknown.

25%confidence

Evidence from the records

  • “"United Kingdom"”
  • “AI agents for knowledge management / corporate training”
  • “Six anonymized use cases (global school chain, mining, telecom, pharma, software publisher, training provider)”
Intro path
Founder-to-founder intro via Ocuwell Limited (network portfolio company of Northern Gritstone).
First step
Check Northern England link.

Tampere spin-off building scalable iPSC-derived corneal cell therapy for limbal stem cell deficiency, targeting first clinical trials around 2027.

Finnish corneal therapy — IP-rich; non-UK.

15%confidence

Evidence from the records

  • “IP-rich businesses”
  • “Ophthalmic cell therapy (cornea)”
  • “Corneal cell therapy at preclinical stage, clinical trials targeted around 2027”
Intro path
Founder-to-founder intro via Ocuwell Limited (network portfolio company of Northern Gritstone).
First step
Low priority.

IIT spin-off selling SiNAPS CMOS neural probes with 1,024 active electrodes for high-density brain recording, an option on brain-computer interfaces.

Italian neural probes — IP-rich; non-UK.

15%confidence

Evidence from the records

  • “IP-rich businesses”
  • “Neurotechnology / neural probes”
  • “The website has a products section and terms of sale, but no customer or user lab is published (conservative estimate).”
Intro path
Founder-to-founder intro via Ocuwell Limited (network portfolio company of Northern Gritstone).
First step
Low priority.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with Deepbridge Capital and LYVA Labs

Sources

  1. 1cbinsights.com/company/ocuwell/financials
  2. 2manchester.ac.uk/discover/news/northern-gritstone-secures-final-close-of-312

Profile compiled from public sources. Unknown fields are left empty rather than estimated.